Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Drug Discovery & Development
How to Improve Therapeutic Efficacy: Safety Considerations in Oncolytic Virotherapy
Oncolytic virotherapy targets cancer cells with viruses, promising personalized treatment with minimal side effects. Safety measures include minimizing off-target effects and systemic spread. Combining with immunotherapy enhances efficacy, revolutionizing cancer treatment.
Drug Discovery & Development
Zika Virus Tested as an Effective Oncolytic Agent for Glioblastoma in In Vitro Models
More results are in for the oncolytic potential of the Zika virus, where it has proven effective against the most common form of brain cancer in vitro.
Oligo Chemistry
Innovation at the Crossroads: Oligonucleotide Therapeutics and the Evolution of Drug Design
Can oligonucleotide therapeutics shape the future of healthcare? We journey through AI frontiers, sustainable synthesis, and regulatory challenges.
Cell Therapy for Solid Tumors: An Innovative Approach to Cancer Treatment
Cell therapy for solid tumours is an innovative cancer treatment that uses a patient's own immune cells or donor cells to fight cancer, but its effectiveness varies by tumour type and patient's immune system. Although it offers new hope, it poses risks such as cytokine release syndrome and neurotoxicity. Recent advancements have led to better targeting, combination therapies, and next-generation treatments, with future research aimed at improving safety, effectiveness, and accessibility, potentially revolutionising cancer care.
Gene Therapy Development
Post-Event Proceedings – Gene Therapy Development & Manufacturing 2023
Concise and insightful summaries of presentations delivered by prominent thought leaders at Gene Therapy Development & Manufacturing 2023.
Drug Discovery & Development
Post-Event Proceedings – Immuno 2023
Concise and insightful summaries of presentations delivered by prominent thought leaders at Immuno 2023.
Advancing Melanoma Treatment: The FDA Gives Lifileucel The Greenlight in Historic Cell & Gene Therapy Breakthrough
The Food and Drug Administration (FDA) approved lifileucel, a one-of-a-kind T-cell therapy developed by Iovance Biotherapeutics for treating melanoma.
.png)
Drug Discovery & Development
In Vivo Models Show Survival Promise for Zika Oncolytic Viral Therapy for Neuroblastoma
One of the deadliest cancers in children could have its survival rate improved by the advent of new research into the oncolytic effect of Zika virus.
eBook: Sustainability & Green Innovations in Pharma and Healthcare
Read how innovators are transforming the industry towards one that prioritizes both healthy patients and a healthy planet.
.png)
Spotlight On: Lindsay Davies, Chief Scientific Officer of NextCell Pharma
We caught up with Lindsay Davies, Chief Scientific Officer of NextCell Pharma, to hear about to hear about the latest advancements in stromal cell therapy in anticipation of her presentation at our Cell & Gene 2024 Congress this November.
Biomarkers & Precision Medicine
New Multi-Omic AI-Driven Initiative for Immuno-Oncology Biomarker Development
The team aims to establish a consortium of cancer centres to join the project of developing biomarkers from multi-omic analysis.
Peptide Chemistry
Recombinant vs. Chemical Peptide Synthesis: A Question of Sustainability
Recombinant and chemical peptide synthesis methods both have use cases in modern peptide production. Today the industry is looking to sustainable approaches to both.